Ginkgo Bioworks

Ginkgo Bioworks secures $275 million in Series D, valuing the company at over $1 billion

Boston biotech startup Ginkgo Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility. The funding comes from previous investors Viking Glo

Biotech startup Zymergen nabs $130 million from Softbank

Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes craz

Ginkgo Bioworks grabs $100 million in financing to buy a whole lot of synthetic DNA

Ginko Bioworks, the Boston-based biotech startup making all sorts of scents and flavors from microbugs, has pulled in $100 million in Series C funding to obtain 600 million base pairs of manufactured

Ginkgo Bioworks Takes On Zymergen With $45 Million In Series B Funding

Boston biotech startup Ginkgo Bioworks just gained an extra $45 million in Series B funding from an "oversubscribed" list of investors. The startup raised $9 million in March, so that gives the startu

Ginkgo Bioworks Lands $9 Million In Series A Funding To Build Out New Lab Facilities

Ginkgo Bioworks, the Boston-based startup working with DARPA and others on wild science projects involving bio-organisms, has just raised $9 Million in Series A Financing from Felicis Ventures, OS Fun

Why The First YC-Backed Biotech Company May Just Be The Future Of Pharma

Gingko Bioworks sounds kind of like a mad science lab of the future. The Boston-based biotech company is currently working on a project with DARPA to treat antibiotic-resistant germs, using designer